Generate Biomedicines, Inc. GENB Balance Sheet Statement
| FY'25 | ||
|---|---|---|
| $121.65M— | ||
| $99.85M— | ||
| $234.37M— | ||
| $29.15M— | ||
| $330.18M— | ||
| —— | ||
| $82.2M— | ||
| $141.55M— | ||
| -$676.29M— | ||
| -$615.97M-41.8% | ||
| $330.18M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Generate Biomedicines, Inc. 's total assets?
- Generate Biomedicines, Inc. (GENB) holds $625.7M in total assets.
- How much debt does Generate Biomedicines, Inc. have?
- Generate Biomedicines, Inc. carries $65.6M in total debt against $514.8M of shareholders' equity, a debt-to-equity ratio of 0.13.
- How much cash does Generate Biomedicines, Inc. have?
- Generate Biomedicines, Inc. holds $160.6M in cash and equivalents.
- Can Generate Biomedicines, Inc. cover its short-term obligations?
- Its current ratio is 9.17 — current assets exceed current liabilities.
- Where does Generate Biomedicines, Inc. 's balance sheet data come from?
- Every line is extracted from Generate Biomedicines, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.